In colorectal cancer, it suppresses cancer progression and is likely to be used as a prognostic predictor26; it also inhibits the metastasis of breast cancer cells by targeting SIAH1 and PTP4A1.27 Consistent with previous reports, our data suggested that miR-944 was significantly downregulated in IPA tissues. Here, PTP4A1 is linked to breast cancer.